NCT03782480View on ClinicalTrials.gov

Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy

PHASE3UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 2, 2019

Primary Completion Date

January 2, 2021

Study Completion Date

January 2, 2021

Conditions
MenopauseGenitourinary Syndrome of MenopauseVulvovaginal AtrophyMenopause SyndromeDyspareunia
Interventions
DRUG

Intrarosa

Prasterone intravaginal inserts

DRUG

Placebos

Placebo intravaginal inserts

Trial Locations (2)

10036

RECRUITING

The Centers for Vulvovaginal Disorders, New York

20037

RECRUITING

The Centers for Vulvovaginal Disorders, Washington D.C.

Sponsors

Collaborators (1)

EndoCeutics Inc.
All Listed Sponsors
collaborator

EndoCeutics Inc.

INDUSTRY

lead

Center for Vulvovaginal Disorders

OTHER

NCT03782480 - Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy | Biotech Hunter | Biotech Hunter